Literature DB >> 9528865

Stimulation of p85/RING3 kinase in multiple organs after systemic administration of mitogens into mice.

J Ostrowski1, S K Florio, G V Denis, H Suzuki, K Bomsztyk.   

Abstract

Using an autophosphorylation membrane assay, we examined activation of kinases in different organs after intraperitoneal injections of mitogens and cytokines into mice. In the multiple organs examined administration of either epidermal growth factor (EGF), phorbol 12-myristate 13-acetate (PMA) or interleukin-1beta (IL-1beta) activated a number of kinases. Most notably among those was a kinase of approximately 85 kDa (p85) that was activated by EGF, PMA and IL-1beta in the lung, kidney, brain, liver and heart. The size and properties of this enzyme are indistinguishable from the RING3 kinase that has a very high activity in leukocytes of patients with leukemia. In animals treated with PMA, antibodies against RING3 kinase immunoprecipitated PMA-responsive p85 activity from the lung and brain suggesting that p85 and RING3 kinases are the same enzymes. Activation of p85/RING3 kinase by growth factors in multiple organs might reflect involvement of this enzyme in the pathogenesis of leukemias and other proliferative diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9528865     DOI: 10.1038/sj.onc.1201624

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

Review 1.  BET domain co-regulators in obesity, inflammation and cancer.

Authors:  Anna C Belkina; Gerald V Denis
Journal:  Nat Rev Cancer       Date:  2012-06-22       Impact factor: 60.716

2.  Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene.

Authors:  G M Platt; G R Simpson; S Mittnacht; T F Schulz
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F.

Authors:  G V Denis; C Vaziri; N Guo; D V Faller
Journal:  Cell Growth Differ       Date:  2000-08

Review 4.  An emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis.

Authors:  Gerald V Denis; Barbara S Nikolajczyk; Gavin R Schnitzler
Journal:  FEBS Lett       Date:  2010-05-21       Impact factor: 4.124

5.  E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia.

Authors:  Rebecca J Greenwald; Joseph R Tumang; Anupama Sinha; Nicolas Currier; Robert D Cardiff; Thomas L Rothstein; Douglas V Faller; Gerald V Denis
Journal:  Blood       Date:  2003-10-16       Impact factor: 22.113

6.  Activation-induced nuclear translocation of RING3.

Authors:  N Guo; D V Faller; G V Denis
Journal:  J Cell Sci       Date:  2000-09       Impact factor: 5.285

7.  Increased constitutive activity of mitogen-activated protein kinase and renaturable 85 kDa kinase in human-colorectal cancer.

Authors:  J Ostrowski; L Trzeciak; J Kołodziejski; K Bomsztyk
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

Review 8.  Pharmacological Targeting of BET Bromodomain Proteins in Acute Myeloid Leukemia and Malignant Lymphomas: From Molecular Characterization to Clinical Applications.

Authors:  Diana Reyes-Garau; Marcelo L Ribeiro; Gaël Roué
Journal:  Cancers (Basel)       Date:  2019-10-02       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.